Matinas BioPharma Holdings Inc

General ticker "MTNB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.0M

Matinas BioPharma Holdings Inc does not follow the US Stock Market performance with the rate: -41.1%.

Estimated limits based on current volatility of 4.4%: low 0.53$, high 0.58$

Factors to consider:

  • Current price 89.3% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.86$, 14.10$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.19$, 15.65$]

Financial Metrics affecting the MTNB estimates:

  • Negative: Non-GAAP EPS, $ of -0.12 <= 0.10
  • Negative: Operating profit margin, % of -95.59 <= 1.03
  • Negative: Operating cash flow per share per price, % of -24.08 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term MTNB quotes

Long-term MTNB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.03MM $3.19MM $1.10MM
Operating Expenses $24.77MM $27.78MM $24.86MM
Operating Income $-24.73MM $-24.59MM $-23.77MM
Non-Operating Income $1.45MM $3.59MM $0.82MM
R&D Expense $14.58MM $16.68MM $14.49MM
Income(Loss) $-23.28MM $-21.00MM $-22.94MM
Profit(Loss) $-23.28MM $-21.00MM $-22.94MM
Stockholders Equity $52.49MM $36.64MM $19.25MM
Assets $61.33MM $44.82MM $25.10MM
Operating Cash Flow $-15.22MM $-19.16MM $-15.28MM
Capital expenditure $0.26MM $0.89MM $0.22MM
Investing Cash Flow $16.77MM $4.88MM $13.24MM
Financing Cash Flow $6.96MM $0.08MM $-0.01MM
Earnings Per Share* $-5.04 $-3.00 $-5.28

* EPS are Split Adjusted, recent splits may be reflected with a delay.